|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||41.66 - 42.01|
|52 Week Range||39.78 - 47.11|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.35%|
Headquartered in New Brunswick, New Jersey, Johnson & Johnson (JNJ) is one of the largest pharmaceutical and healthcare companies in the world.
Antibiotics are the most commonly prescribed class of drug, and represent a $40 billion market globally. There have only been 10 new Food and Drug Administration approvals for antibiotics since 2010, and while they were developed by eight different companies, now just four--Allergan (AGN), Johnson & Johnson (JNJ), Merck (MRK), and Melinta Therapeutics (MLNT)--own them.
Investors looking to play a rebound in pharmaceuticals stocks have an array of exchange traded funds to consider. The SPDR Pharmaceuticals ETF (NYSEArca: XPH) is an equal-weight approach to pharmaceuticals ...
Trump described drug prices as “one of my greatest priorities,” but his administration has released nothing in the way of policy over the last year.
As we saw in Part 1 of this series, Johnson & Johnson (JNJ) is expected to report a 10.9% growth in revenue to $20.1 billion in 4Q17 compared to 4Q16. The above chart compares the actual revenues for Johnson & Johnson since 1Q16 and estimates for 4Q17. In 4Q17, the segment is expected to report growth in operating revenues, with a favorable impact from foreign exchange.
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has been on a tear in recent months, nearly doubling since November 1, when it closed at $11.93 a share. Valeant announced its results on November 7, with the news it beat analyst estimates for both revenue and net income. The company has also made progress in reducing its substantial debt burden.
CNBC's Mike Santoli takes a look at which ETFs could be affected by the announcement that J.P. Morgan, Berkshire Hathaway and Amazon are teaming up to form a health-care company.
CEO of pharmaceutical company Mylan, Heather Bresch, sits down the Yahoo Finance's Andy Serwer and Jen Rogers to discuss what the future holds for the drug company.